{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:09:53Z","timestamp":1761998993196,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:00:00Z","timestamp":1499904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11894-017-0571-z","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T02:54:54Z","timestamp":1499914494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective"],"prefix":"10.1007","volume":"19","author":[{"given":"Randolph","family":"McConnie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Kastl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"key":"571_CR1","first-page":"569","volume-title":"Clinical Gastroenterology","author":"H Spiro","year":"1983","unstructured":"Spiro H. Antibiotic-associated colitis and enteritis. In: Spiro H, editor. Clinical Gastroenterology. New York: Macmillan Publishing Co, Inc; 1983. p. 569\u201370."},{"key":"571_CR2","unstructured":"Gryboski J, Walker WA. \u201cDiarrhea: Acute and Chronic\u201d. In Gastrointestinal Problems in the Infant, Second Edition. Philadelphia: W.B. Saunders Company; 1983. pp. 558\u2013559."},{"issue":"3","key":"571_CR3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1128\/CMR.00016-13","volume":"26","author":"CA Burnham","year":"2013","unstructured":"\u2022\u2022 Burnham CA, Caroll KC. Diagnosis of Clostridium dificile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev. 2013;26(3):604\u201330. Excellent review of C. diff, its biology, testing, and disease in humans.","journal-title":"Clin Microbiol Rev"},{"key":"571_CR4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archpedi.1935.01970020105010","volume":"49","author":"IC Hall","year":"1935","unstructured":"Hall IC, O\u2019Tooke E. Intestinal flora in newborn infants: with a description of a new pathogenic anaerobe, Bacillus dificilis. Am J Dis Child. 1935;49:390\u2013402.","journal-title":"Am J Dis Child"},{"key":"571_CR5","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/bmj.1.6071.1246","volume":"1","author":"HE Larson","year":"1977","unstructured":"Larson HE, Parry JV, Price AB, et al. Undescribed toxin in pseudomembranous colitis. Br Med J. 1977;1:1246\u20138.","journal-title":"Br Med J"},{"key":"571_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/infdis\/136.5.701","volume":"136","author":"JG Bartlett","year":"1977","unstructured":"Bartlett JG, Onderdonk AB, Cisneros RL, et al. Clincamycin associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis. 1977;136:701\u20135.","journal-title":"J Infect Dis"},{"key":"571_CR7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197803092981003","volume":"298","author":"JG Bartlett","year":"1978","unstructured":"Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic associated pseudomembranous colitis due to toxin-producing clostridia. NEJM. 1978;298:531\u20134.","journal-title":"NEJM"},{"issue":"10","key":"571_CR8","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/cid\/ciu125","volume":"58","author":"I Lee","year":"2014","unstructured":"\u2022 Lee I, Mu Y, Cohen J, et al. NAP1 strain type predicts outcome from Clostridium Difficile infections. Clin Infect Dis. 2014;58(10):1394\u2013400. Sobering report of NAP1\u2019s association with severe disease.","journal-title":"Clin Infect Dis"},{"key":"571_CR9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","volume":"372","author":"FC Lessa","year":"2015","unstructured":"\u2022 Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825\u201334. Excellent study looking at the burden of C. diff. disease in 2011","journal-title":"N Engl J Med"},{"issue":"11","key":"571_CR10","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.3748\/wjg.v22.i11.3078","volume":"22","author":"LV McFarland","year":"2016","unstructured":"\u2022 McFarland LV, Ozen M, Dinleyici EC, Goh S. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol. 2016;22(11):3078\u2013104. Excellent review of pediatric vs. adult C. diff. induced disease","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"571_CR11","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/521863","volume":"46","author":"JG Bartlett","year":"2008","unstructured":"Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium dificile infection. Clin Infect Dis. 2008;46(Suppl 1):S12\u20138.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"571_CR12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","volume":"31","author":"HC Stuart","year":"2010","unstructured":"Stuart HC, Dale NG, Stuart J. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431\u201355.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"571_CR13","doi-asserted-by":"publisher","first-page":"e7396","DOI":"10.1136\/bmj.e7396","volume":"345","author":"MK Bomers","year":"2010","unstructured":"Bomers MK, van Agtmael MA, Luik H, et al. Using a dog\u2019s superior olfactory sensitivity to identify Clostridium Difficile in stools and patients: proof of principle study. BMJ. 2010;345:e7396. doi:\n10.1136\/bmj.e7396\n\n.","journal-title":"BMJ"},{"issue":"3","key":"571_CR14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/INF.0000000000001008","volume":"35","author":"M Gonzalez del Vecchio","year":"2016","unstructured":"Gonzalez del Vecchio M, Alvarez Uria A, Marin M, et al. Clinical significance of Clostridium dificille in children less than 2 years old: a case-control study. Pediatr Infect Dis J. 2016;35(3):281\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"571_CR15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archpedi.1981.02130330032010","volume":"135","author":"SP Adler","year":"1981","unstructured":"Adler SP, Chandrike T, Berman WF. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12 week old infant without prior antibiotic therapy. Am J Dis Child. 1981;135:820.","journal-title":"Am J Dis Child"},{"issue":"Supplement 2","key":"571_CR16","first-page":"S154","volume":"61","author":"A Kastl","year":"2015","unstructured":"Kastl A, McConnie R. Clostridium difficile under the microscope: rates of C. Diff toxin detection and clinically significant colitis found at the time of colonoscopy. JPGN. 2015;61(Supplement 2):S154.","journal-title":"JPGN"},{"issue":"10","key":"571_CR17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1099\/00222615-47-10-879","volume":"47","author":"SD Dallas","year":"1998","unstructured":"Dallas SD, Rolfe RD. Binding of Clostridium difficile toxin: a human milk secretory component. J Med Microbiol. 1998;47(10):879\u201388.","journal-title":"J Med Microbiol"},{"issue":"1","key":"571_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1099\/00222615-42-1-10","volume":"42","author":"RD Rolfe","year":"1995","unstructured":"Rolfe RD, Song W. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding. J Med Microbiol. 1995;42(1):10\u20139.","journal-title":"J Med Microbiol"},{"key":"571_CR19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/cid\/cis637","volume":"55","author":"C Rousseau","year":"2012","unstructured":"Rousseau C, Poilane I, De Pontual L, et al. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis. 2012;55:1209\u201315.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"571_CR20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1172\/JCI115957","volume":"90","author":"R Eglow","year":"1992","unstructured":"Eglow R, Pohtoulakis C, Itzkowitz S, et al. Diminished Clostridium difficile toxin a sensitivity in newborn rabbit ileum is associated with decreased toxin a receptor. J Clin Invest. 1992;90(3):822\u20139.","journal-title":"J Clin Invest"},{"key":"571_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1542\/peds.2012-2992","volume":"131","author":"GE Schute","year":"2013","unstructured":"Schute GE, Willoughby RE. Clostridium difficile infection in infants and children. Pediatrics. 2013;131:196\u2013200.","journal-title":"Pediatrics"},{"key":"571_CR22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.gtc.2012.01.003","volume":"41","author":"A Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan A. Detetcing and treating Clostridium difficile infections in patients with inflammatory bowel disease. Gastroenterol Clin N Am. 2012;41:339\u201353.","journal-title":"Gastroenterol Clin N Am"},{"key":"571_CR23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","volume":"5","author":"M Issa","year":"2007","unstructured":"Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345\u201351.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"571_CR24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2036.2009.04229.x","volume":"31","author":"R Turco","year":"2010","unstructured":"Turco R, Martinelli M, Miele E, et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther. 2010;31(7):754.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"571_CR25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","volume":"107","author":"S Janarthanan","year":"2012","unstructured":"Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012;107(7):1001.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"571_CR26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/cid\/civ432","volume":"61","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Lamous\u00e9-Smith ES, Lightdale JR, et al. Use of acid suppression medication is associated with risk for C. difficile infection in infants and children: a population-based study. Clin Infect Dis. 2015;61(6):912.","journal-title":"Clin Infect Dis"},{"key":"571_CR27","unstructured":"\u2022 American Academy of Pediatrics, Committee on Infectious Diseases. Clostridium Dificile. In: Kimberlin DW, Brady MR, Jackson MA, Long SS, editors. Red book: 2015 report of the Committee on Infectious Diseases, 30 th. Elk Grove Village: American Academy of Peidatrics. p. 298\u2013301. Presents guidelines regarding treatment in children."},{"issue":"6","key":"571_CR28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1542\/peds.2010-2548","volume":"126","author":"DW Thomas","year":"2010","unstructured":"Thomas DW, Greer FR. American Academy of Pediatrics, Committee on nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126(6):1217\u201331.","journal-title":"Pediatrics"},{"key":"571_CR29","doi-asserted-by":"crossref","unstructured":"Wilcox MH, Gerding DN, Poxton IR, et. al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med. 2017;376:305\u201317.","DOI":"10.1056\/NEJMoa1602615"},{"key":"571_CR30","doi-asserted-by":"crossref","unstructured":"Bartlett JG. Bezlotoxumab. A new agent for Clostridium difficile infection. N Engl J Med. 2017;376:381\u20132.","DOI":"10.1056\/NEJMe1614726"},{"issue":"6","key":"571_CR31","first-page":"667","volume":"36","author":"HL Koo","year":"2014","unstructured":"Koo HL, Van JN, Zhao M, et al. Real\u2013time Plymearase chain reaction detection of asymptomatic Clostricium dificille colonization and rising C. Dificille-associated disease rates. Infect Control Hosp Epidemiol. 2014;36(6):667\u201373.","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-017-0571-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-017-0571-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-017-0571-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T03:47:57Z","timestamp":1501472877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-017-0571-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1007\/s11894-017-0571-z","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"type":"print","value":"1522-8037"},{"type":"electronic","value":"1534-312X"}],"subject":[],"published":{"date-parts":[[2017,7,13]]},"article-number":"34"}}